RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Helius Medical Technologies Stock

Helius Medical Technologies ROA 2024

Helius Medical Technologies ROA

-1.15

Ticker

HSDT

ISIN

US42328V6039

WKN

A2JB8E

In 2024, Helius Medical Technologies's return on assets (ROA) was -1.15, a 41.34% increase from the -0.81 ROA in the previous year.

Helius Medical Technologies Aktienanalyse

What does Helius Medical Technologies do?

Helius Medical Technologies Inc is a Canadian company that specializes in the development and marketing of novel medical devices. The company was founded in 2014 and has since experienced remarkable success. The company's main product is the Portable Neuromodulation Stimulation (PoNS) treatment, which offers a non-invasive therapy for conditions such as stroke, traumatic brain injury, or multiple sclerosis. It is a portable device applied to the patient's tongue, emitting weak electrical impulses to promote neural stimulation. The accompanying software allows clinics and hospitals to offer personalized treatment to patients. Helius Medical Technologies Inc is divided into various divisions to better organize its operations: development, sales, and research and development. The different divisions are designed to operate the core business independently. The company operates in North America, with its headquarters in Newtown, Pennsylvania. However, it also operates in Canada and other regions, including Europe, Latin America, and Asia. Helius Medical Technologies Inc maintains close ties to the scientific community to ensure its products are up to date. The company has also partnered with the Walter Reed National Military Medical Center to explore the potential of its PoNS technology in treating post-traumatic stress disorder (PTSD) in US military personnel and veterans. The business model of Helius Medical Technologies Inc is based on innovative solutions that enable top-notch medical treatments. Through continuous research and development, the company remains at the forefront of the medical technology industry. Helius Medical Technologies Inc is focused on growth, reflected in its ongoing search for new markets and products. In recent years, the company has experienced significant growth, driven by the introduction of its PoNS treatment and various shareholder investments. The revenue of Helius Medical Technologies Inc has steadily increased since its founding, thanks to the support of its customers and investors. In summary, Helius Medical Technologies Inc is a leading company in the field of medical technology. Through innovative research and development, the company has achieved impressive success in a short period of time. The PoNS treatment is a groundbreaking technology that will gain global significance in the future. Helius Medical Technologies Inc remains focused on growth, with a strong vision that enables it to improve the quality of healthcare worldwide. Helius Medical Technologies ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding Helius Medical Technologies's Return on Assets (ROA)

Helius Medical Technologies's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Helius Medical Technologies's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Helius Medical Technologies's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Helius Medical Technologies’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Helius Medical Technologies stock

What is the Return on Assets (ROA) of Helius Medical Technologies this year?

The Return on Assets (ROA) of Helius Medical Technologies is -1.15 undefined this year.

What was the ROA of Helius Medical Technologies compared to the previous year?

The ROA of Helius Medical Technologies has increased by 41.34% compared to the previous year.

What consequences do high ROA have for investors of Helius Medical Technologies?

A high ROA is advantageous for investors of Helius Medical Technologies, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in Helius Medical Technologies?

A low ROA can be unfavorable for investors of Helius Medical Technologies as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of Helius Medical Technologies affect the company?

An increase in ROA of Helius Medical Technologies can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of Helius Medical Technologies impact the company?

A reduction in the ROA of Helius Medical Technologies can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of Helius Medical Technologies?

Some factors that can influence the ROA of Helius Medical Technologies include revenue, operating costs, asset structure, and industry average.

Why is the ROA of Helius Medical Technologies important for investors?

The ROA of Helius Medical Technologies is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can Helius Medical Technologies take to improve ROA?

To improve ROA, Helius Medical Technologies can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does Helius Medical Technologies pay?

Over the past 12 months, Helius Medical Technologies paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Helius Medical Technologies is expected to pay a dividend of 0 USD.

What is the dividend yield of Helius Medical Technologies?

The current dividend yield of Helius Medical Technologies is .

When does Helius Medical Technologies pay dividends?

Helius Medical Technologies pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Helius Medical Technologies?

Helius Medical Technologies paid dividends every year for the past 0 years.

What is the dividend of Helius Medical Technologies?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Helius Medical Technologies located?

Helius Medical Technologies is assigned to the 'Health' sector.

Wann musste ich die Aktien von Helius Medical Technologies kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Helius Medical Technologies from 12/30/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 12/30/2024.

When did Helius Medical Technologies pay the last dividend?

The last dividend was paid out on 12/30/2024.

What was the dividend of Helius Medical Technologies in the year 2023?

In the year 2023, Helius Medical Technologies distributed 0 USD as dividends.

In which currency does Helius Medical Technologies pay out the dividend?

The dividends of Helius Medical Technologies are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Helius Medical Technologies

Our stock analysis for Helius Medical Technologies Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Helius Medical Technologies Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.